BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roohullah A, Wong HL, Sjoquist KM, Gibbs P, Field K, Tran B, Shapiro J, Mckendrick J, Yip D, Nott L, Gebski V, Ng W, Chua W, Price T, Tebbutt N, Chantrill L. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab. World J Gastroenterol 2015; 21(17): 5352-5358 [PMID: 25954110 DOI: 10.3748/wjg.v21.i17.5352]
URL: https://www.wjgnet.com/1007-9327/full/v21/i17/5352.htm
Number Citing Articles
1
Yukiya Narita, Kei Muro. Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safetyExpert Opinion on Drug Safety 2017; 16(3): 319 doi: 10.1080/14740338.2017.1273348
2
Siavash Foroughi, Hui‐li Wong, Lucy Gately, Margaret Lee, Koen Simons, Jeanne Tie, Antony Wilks Burgess, Peter Gibbs. Re‐inventing the randomized controlled trial in medical oncology: The registry‐based trialAsia-Pacific Journal of Clinical Oncology 2018; 14(6): 365 doi: 10.1111/ajco.12992
3
Long Bai, Feng Wang, Zhe-zhen Li, Chao Ren, Dong-sheng Zhang, Qi Zhao, Yun-xin Lu, De-shen Wang, Huai-qiang Ju, Miao-zhen Qiu, Zhi-qiang Wang, Feng-hua Wang, Rui-hua Xu. Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancerMedicine 2016; 95(51): e4531 doi: 10.1097/MD.0000000000004531
4
S.I. Panin, V.A. Suvorov, N.V. Kovalenko, A.V. Bykov, M.P. Postolov, A.M. Linchenko, O.A. Kosivtsov, E.S. Mikhin. Perforated peptic ulcer in patients with cancer: prediction of postoperative morbidity and mortalityKhirurgiya. Zhurnal im. N.I. Pirogova 2022; (7): 12 doi: 10.17116/hirurgia202207112